Comparative efficacy and tolerability of anti‐epileptic drugs for refractory focal epilepsy: systematic review and network meta‐analysis reveals the need for long term comparator trials

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.12083PMID 23351090PMCID PMC3853525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency’s Committee for Medicinal Products for Human Use

  2017cited by this paper
• More on influenza vaccine in young children.

  2012cited by this paper
• NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials

  2011cited by this paper
• Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta‐analysis

  2011cited by this paper
• A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures.

  2010cited by this paper
• Industry sponsorship and selection of comparators in randomized clinical trials

  2010cited by this paper
• Placebo‐corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta‐analysis

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

  2009cited by this paper
• Pregabalin add‐on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: A double‐blind, randomized, placebo‐controlled, multicenter trial

  2009cited by this paper
• The mad world of epilepsy drugs

  2009cited by this paper
• Comparative Effectiveness Research: A Report From the Institute of Medicine

  2009cited by this paper
• A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

  2009cited by this paper
• Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment–Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies

  2009cited by this paper
• Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

  2009cited by this paper
• Efficacy and Safety of Levetiracetam (3,000 mg/Day) as an Adjunctive Therapy in Chinese Patients with Refractory Partial Seizures

  2009cited by this paper
• Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses

  2009cited by this paper
• Once‐daily extended‐release levetiracetam as adjunctive treatment of partial‐onset seizures in patients with epilepsy: A double‐blind, randomized, placebo‐controlled trial

  2009cited by this paper
• Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified.

  2008cited by this paper
• Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.

  2008cited by this paper
• Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.

  2008cited by this paper
• Evaluation of networks of randomized trials

  2008cited by this paper
• Exploring the Geometry of Treatment Networks

  2008cited by this paper
• Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures

  2007cited by this paper
• Institute of Medicine Roundtable on Evidence-Based Medicine

  2007cited by this paper
• The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

  2007cited by this paper
• Lamotrigine extended-release as adjunctive therapy for partial seizures

  2007cited by this paper
• The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

  2007cited by this paper
• Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Study

  2006cited by this paper
• Treatment of partial seizures with gabapentin: Double‐blind, placebo‐controlled, parallel‐group study *

  2006cited by this paper
• Dose‐dependent Safety and Efficacy of Zonisamide: A Randomized, Double‐blind, Placebo‐controlled Study in Patients with Refractory Partial Seizures

  2005cited by this paper
• Meta-Analysis and Indirect Comparisons of Levetiracetam With Other Second-Generation Antiepileptic Drugs in Partial Epilepsy

  2005cited by this paper
• Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures

  2005cited by this paper
• Response to Antiepileptic Drug Therapy: Winners and Losers

  2005cited by this paper
• Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

  2005cited by this paper
• Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy

  2005cited by this paper
• Randomized, Controlled Clinical Trial of Zonisamide as Adjunctive Treatment for Refractory Partial Seizures

  2004cited by this paper
• Combination of direct and indirect evidence in mixed treatment comparisons

  2004cited by this paper
• Pregabalin Add‐on Treatment: A Randomized, Double‐blind, Placebo‐controlled, Dose–Response Study in Adults with Partial Seizures

  2004cited by this paper
• The treatment of epilepsy

  2004cited by this paper
• Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.

  2004cited by this paper
• Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation

  2004cited by this paper
• Zonisamide clinical trials: European experience.

  2004cited by this paper
• Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

  2004cited by this paper
• Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

  2003cited by this paper
• Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

  2003cited by this paper
• How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study.

  2003cited by this paper
• Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

  2003cited by this paper
• The inclusion of reports of randomised trials published in languages other than English in systematic reviews.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Bayesian measures of model complexity and fit

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.

  2002cited by this paper
• Network meta‐analysis for indirect treatment comparisons

  2002cited by this paper
• Meta-Analysis of Controlled Clinical Trials

  2002cited by this paper
• Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.

  2001cited by this paper
• Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

  2001cited by this paper
• Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.

  2001cited by this paper
• Bayesian methods in meta-analysis and evidence synthesis.

  2001cited by this paper
• Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.

  2001cited by this paper
• Glossary of Descriptive Terminology for Ictal Semiology: Report of the ILAE Task Force on Classification and Terminology

  2001cited by this paper
• Safety and efficacy of standard and new antiepileptic drugs.

  2000cited by this paper
• A Double‐Blind, Placebo‐Controlled Study of Topiramate in Adult Patients with Refractory Partial Epilepsy

  2000cited by this paper
• Gabapentin Versus Vigabatrin as First Add‐On for Patients with Partial Seizures That Failed to Respond to Monotherapy: A Randomized, Double‐Blind, Dose Titration Study

  2000cited by this paper
• Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating Monotherapy

  2000cited by this paper
• Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures

  2000cited by this paper
• A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

  2000cited by this paper
• WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility

  2000cited by this paper
• Levetiracetam for partial seizures

  2000cited by this paper
• Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.

  2000cited by this paper
• Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.

  2000cited by this paper
• Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy

  2000cited by this paper
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

  1999cited by this paper
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

  1999cited by this paper
• Patients with refractory seizures.

  1999cited by this paper
• Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.

  1999cited by this paper
• Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

  1998cited by this paper
• A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

  1998cited by this paper
• General methods for monitoring convergence of iterative simulations

  1998cited by this paper
• A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.

  1998cited by this paper
• The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability

  1997cited by this paper
• The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials.

  1997cited by this paper
• The Epidemiology and Treatment of Chronic and Refractory Epilepsy

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages

  1996cited by this paper
• Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy

  1996cited by this paper
• New antiepileptic drugs: a systematic review of their efficacy and tolerability

  1996cited by this paper
• Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.

  1996cited by this paper
• A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages

  1996cited by this paper
• Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures

  1996cited by this paper
• Remission of epilepsy: results from the National General Practice Study of Epilepsy.

  1995cited by this paper
• Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial

  1994cited by this paper
• Gabapentin (Neurontin) as Add‐on Therapy in Patients with Partial Seizures: A Double‐Blind, Placebo‐Controlled Study

  1994cited by this paper
• Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.

  1993cited by this paper
• Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures

  1993cited by this paper
• Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

  1993cited by this paper
• Double‐Blind Study of Gabapentin in the Treatment of Partial Seizures

  1991cited by this paper
• Gabapentin in partial epilepsy

  1990cited by this paper
• A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures.

  1990cited by this paper
• Gabapentin in partial epilepsy. UK Gabapentin Study Group.

  1990cited by this paper

• Effectiveness and safety of single anti-seizure medication as adjunctive therapy for drug-resistant focal epilepsy based on network meta-analysis

  2025cites this paper
• Epilepsy associated with brain meningiomas

  2025cites this paper
• New possibilities of overcoming pharmacoresistance in epilepsy

  2024cites this paper
• The effects of gabapentin and antidepressants on opioid-related mortality rates: physicians who can "see and hear," must also "look and listen".

  2024cites this paper
• Gliomagenesis, Epileptogenesis, and Remodeling of Neural Circuits: Relevance for Novel Treatment Strategies in Low- and High-Grade Gliomas

  2024cites this paper
• Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials

  2024cites this paper
• Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy

  2023cites this paper
• Vigabatrin (Sabril) for the Treatment of Refractory Complex Focal Seizures in Adults: Pharmacologic and Clinical Considerations

  2023cites this paper
• Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis

  2023cites this paper
• Sodium Valproate Combined With Topiramate vs. Sodium Valproate Alone for Refractory Epilepsy: A Systematic Review and Meta-Analysis

  2022cites this paper
• Approach to the Medical Treatment of Epilepsy

  2022cites this paper
• Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials

  2021cites this paper
• Gabapentin add-on treatment for drug-resistant focal epilepsy.

  2021cites this paper
• Antiepileptic drug add-on therapy for focal epilepsy: a network meta-analysis

  2021influential citation
• Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta‐analyses and real‐world evidence on antiepileptic drugs

  2020cites this paper
• Network meta-analysis of antiepileptic drugs in focal drug-resistant epilepsy.

  2020cites this paper
• Polytherapie

  2020cites this paper
• Medikamentöse Therapie von epileptischen Anfällen und Epilepsien

  2019cites this paper
• An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.

  2019cites this paper
• Relative performance of brivaracetam as adjunctive treatment of focal seizures in adults: a network meta-analysis

  2019cites this paper
• The Association Between Psychotropic Drug Use and Fertility Problems Among Male Subjects

  2019cites this paper
• Seizures as Complications in Cancer

  2018cites this paper
• Federation of Neuro-Oncology Societies

  2018cites this paper
• levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.

  2018cites this paper
• levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy

  2018cites this paper
• Gabapentin add-on treatment for drug-resistant focal epilepsy.

  2018cites this paper
• Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• DGN-Leitlinie Epilepsie — was ist für die Praxis wichtig?

  2018cites this paper
• Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?

  2017cites this paper
• Evaluate the Efficacy and Safety of Anti‐Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta‐Analysis

  2017cites this paper
• Tolerability of new antiepileptic drugs: a network meta-analysis

  2017cites this paper
• Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis

  2017cites this paper
• Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma

  2017cites this paper
• Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.

  2016cites this paper
• Response to "Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison".

  2016cites this paper
• Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.

  2016cites this paper
• WHO classifi cation of central nervous system tumors 2016 : integration of histological features and molecular biomarkers for improved glioma diagnostics

  2016cites this paper
• A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.

  2016cites this paper
• Seizures and gliomas — towards a single therapeutic approach

  2016cites this paper
• Epilepsy and brain tumors.

  2016cites this paper
• The adverse event profile of levetiracetam: A meta-analysis on children and adults.

  2015cites this paper
• What is New in the Management of Epilepsy in Gliomas?

  2015cites this paper
• Optimising Epilepsy Therapy – Searching for the Evidence – Looking Beyond the Data

  2015cites this paper
• Seizures in oligodendroglial tumors.

  2015cites this paper
• Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective

  2014cites this paper
• Topiramate for smoking cessation: a randomized, placebo-controlled pilot study.

  2014cites this paper
• Seizure prognosis in brain tumors: new insights and evidence-based management.

  2014cites this paper
• Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial

  2014cites this paper
• Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy.

  2013cites this paper
• Qué aportan los nuevos fármacos antiepilépticos

  2013cites this paper
• Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation.

  2013cites this paper